Series D+-stage Healthcare AI investors
Healthcare AI investors writing series d+-stage checks. Cross-referenced with portfolio holdings, sub-vertical focus, and check-size range so you can shortlist credible leads for your raise.
Series D and subsequent funding rounds are highly advanced capital injections utilized by mature, pre-IPO companies. Startups raise these mega-rounds to finalize strategic acquisitions, weather unfavorable public market conditions, or achieve absolute global market dominance before executing a highly anticipated initial public offering or corporate sale.
63
investors match
Within Series D+: top healthcare sub-verticals
AXA Venture Partners
Corporate VC
AI
T3
Digital Health
Health IT / Healthcare Software
Balyasny Asset Management
PE
T3
Biotech
Pharma / Therapeutics
Deerfield Management
PE
AI
T1
Health IT / Healthcare Software
Life Sciences Tools
Erez Capital
VC
T3
AI/ML in Healthcare
Digital Health
Foresite Capital
VC
T3
AI/ML in Healthcare
Biotech
Formation Bio
VC
T3
AI/ML in Healthcare
Biotech
Founders Fund
VC
T1
AI/ML in Healthcare
Biotech
Georgian
VC
T3
AI/ML in Healthcare
Digital Health
GIC
PE
T2
Digital Health
Pharma / Therapeutics
Graphene Ventures
VC
T3
AI/ML in Healthcare
Digital Health
Greycroft
VC
T3
AI/ML in Healthcare
Care Delivery / Tech-Enabled Services
GSK
Corporate VC
T3
AI/ML in Healthcare
Biotech
GSR Ventures
VC
T3
AI/ML in Healthcare
Care Delivery / Tech-Enabled Services
Horizons Ventures
Family Office
T3
AI/ML in Healthcare
Biotech
HUMAN CAPITAL
VC
T3
AI/ML in Healthcare
Biotech